Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Number of holders
-
484
-
Total 13F shares, excl. options
-
92,070,273
-
Shares change
-
-1,258,306
-
Total reported value, excl. options
-
$9,405,178,680
-
Value change
-
-$118,631,518
-
Put/Call ratio
-
77%
-
Number of buys
-
241
-
Number of sells
-
-181
-
Price
-
$102.15
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q3 2014
528 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q3 2014.
Edwards Lifesciences Corp - Common Stock (EW) has 484 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92,070,273 shares
of 590,231,680 outstanding shares and own 16% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (10,738,100 shares), VANGUARD GROUP INC (8,391,200 shares), Capital World Investors (5,979,400 shares), GENERATION INVESTMENT MANAGEMENT LLP (5,567,081 shares), FMR LLC (4,962,672 shares), State Street Corp (4,686,924 shares), WELLINGTON MANAGEMENT CO LLP (4,328,837 shares), BlackRock Institutional Trust Company, N.A. (2,779,445 shares), BlackRock Fund Advisors (1,616,858 shares), and NORTHERN TRUST CORP (1,419,339 shares).
This table shows the top 484 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.